Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$256K Sell
916
-61
-6% -$16K 0.17% 88
2026
Q1
$261K Buy
977
+132
+16% +$35.7K 0.24% 81
2025
Q4
$212K Buy
+845
New +$224K 0.2% 87

Other funds holding LH

Lawood & Co's LH Position: Q2 2026 in Review

Lawood & Co reduced its Labcorp (LH) stake by 6.2% in Q2 2026, selling an estimated $16K and leaving 916 shares worth $256K. The position accounts for 0.17% of the portfolio, ranked #88.

Lawood & Co first reported a position in LH in Q4 2025 and has held it in 3 quarters since. The position peaked at $261K in Q1 2026. 1,054 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Lawood & Co held 916 shares of Labcorp worth $256K as of Q2 2026.
  • Lawood & Co sold 61 Labcorp shares in Q2 2026, an estimated $16K.
  • Labcorp made up 0.17% of Lawood & Co's portfolio in Q2 2026, its #88 holding.
  • Lawood & Co first reported a position in Labcorp in Q4 2025 and has held it in 3 quarters since.
  • Lawood & Co's Labcorp position peaked at $261K in Q1 2026.
  • 1,054 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Lawood & Co's 13F filing for Q2 2026, filed 13 Jul 2026.